Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07061613 · ClinicalTrials.gov registry record · NA
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers
A NA study of Venous Leg Ulcer, sponsored by NuScience Medical Biologics.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 2
- Study locations
NCT07061613: Recruiting NA study of Venous Leg Ulcer, sponsored by NuScience Medical Biologics.
NCT07061613 is a NA study of Venous Leg Ulcer that is actively recruiting participants, run by NuScience Medical Biologics. The registered enrollment target is 10 participants, below the 245-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07061613, a NA study of Venous Leg Ulcer, is actively recruiting participants, sponsored by NuScience Medical Biologics.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Venous Leg Ulcers
Primary Outcome
The primary endpoint will be the percentage of target ulcers that achieve complete wound closure.
Conditions Studied
Interventions
- OTHER NeoThelium FT (HCT/P 361)
Study Locations (2)
Louisiana
- MedCentris of Metairie - Metairie
- MedCentris of Slidell - Slidell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2026-07-29 |
| Phase | NA |
What NCT07061613 shows while recruiting
NCT07061613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 245-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 1 intervention - of which NeoThelium FT (HCT/P 361) is the first listed.
NCT07061613 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT07061613 about?
NCT07061613 is a clinical study titled "Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers". This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Venous Leg Ulcers
What is the current status of trial NCT07061613?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-09-02. Estimated completion is 2026-07-29.
What conditions does trial NCT07061613 study?
This clinical trial studies the following conditions: Venous Leg Ulcer.
What interventions are being tested in trial NCT07061613?
The interventions under investigation include: NeoThelium FT (HCT/P 361) (OTHER).
Who is sponsoring clinical trial NCT07061613?
This trial is sponsored by NuScience Medical Biologics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07061613 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07061613's enrollment target sits among peer trials
10 35th of 35 the lowest of 35 other Venous Leg Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI